Discovery and characterization of selective small molecule inhibitors of the mammalian mitochondrial division dynamin, DRP1

被引:23
|
作者
Mallat, A. [1 ]
Uchiyama, L. F. [2 ]
Lewis, S. C. [2 ]
Fredenburg, R. A. [1 ]
Terada, Y. [3 ]
Ji, N. [1 ]
Nunnari, J. [2 ]
Tseng, C. C. [1 ]
机构
[1] Mitobridge Inc, Cambridge, MA 02138 USA
[2] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA
[3] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki, Japan
关键词
DRP1; Mitochondria; Small molecule inhibitor; Fission; Dynamics; FISSION; FUSION; NEURODEGENERATION; PROTEIN-1; PROTECTS;
D O I
10.1016/j.bbrc.2018.03.189
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Balanced rates of mitochondrial division and fusion are required to maintain mitochondrial function, as well as cellular and organismal homeostasis. In mammals, the cellular machines that mediate these processes are dynamin-related GTPases; the cytosolic DRP1 mediates division, while the outer membrane MFN1/2 and inner membrane OPA1 mediate fusion. Unbalanced mitochondrial dynamics are linked to varied pathologies, including cell death and neurodegeneration, raising the possibility that small molecules that target the division and fusion machines to restore balance may have therapeutic potential. Here we describe the discovery of novel small molecules that directly and selectively inhibit assembly-stimulated GTPase activity of the division dynamin, DRP1. In addition, these small molecules restore wild type mtDNA copy number in MFN1 knockout mouse embryonic fibroblast cells, a phenotype linked to deficient mitochondrial fusion activity. Thus, these compounds are unique tools to explore the roles of mitochondrial division in cells, and to assess the potential therapeutic efficacy of rebalancing mitochondrial dynamics in pathologies associated with excessive mitochondrial division. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:556 / 562
页数:7
相关论文
共 50 条
  • [31] Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3
    Huard, Kim
    Londregan, Allyn T.
    Tesz, Gregory
    Bahnck, Kevin B.
    Magee, Thomas V.
    Hepworth, David
    Polivkova, Jana
    Coffey, Steven B.
    Pabst, Brandon A.
    Gosset, James R.
    Nigam, Anu
    Kou, Kou
    Sun, Hao
    Lee, Kyuha
    Herr, Michael
    Boehm, Markus
    Carpino, Philip A.
    Goodwin, Bryan
    Perreault, Christian
    Li, Qifang
    Jorgensen, Csilla C.
    Tkalcevic, George T.
    Subashi, Timothy A.
    Ahn, Kay
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (18) : 7164 - 7172
  • [32] Alterations in c-Myc phenotypes resulting from dynamin-related protein 1 (Drp1)-mediated mitochondrial fission
    Sarin, M.
    Wang, Y.
    Zhang, F.
    Rothermund, K.
    Zhang, Y.
    Lu, J.
    Sims-Lucas, S.
    Beer-Stolz, D.
    Van Houten, B. E.
    Vockley, J.
    Goetzman, E. S.
    Graves, J. Anthony
    Prochownik, E. V.
    CELL DEATH & DISEASE, 2013, 4 : e670 - e670
  • [33] Alterations in c-Myc phenotypes resulting from dynamin-related protein 1 (Drp1)-mediated mitochondrial fission
    M Sarin
    Y Wang
    F Zhang
    K Rothermund
    Y Zhang
    J Lu
    S Sims-Lucas
    D Beer-Stolz
    B E Van Houten
    J Vockley
    E S Goetzman
    J Anthony Graves
    E V Prochownik
    Cell Death & Disease, 2013, 4 : e670 - e670
  • [34] Development of 2-Thioxoquinazoline-4-one Derivatives as Dual and Selective Inhibitors of Dynamin-Related Protein 1 (Drp1) and Puromycin-Sensitive Aminopeptidase (PSA)
    Numadate, Akiyoshi
    Mita, Yusuke
    Matsumoto, Yotaro
    Fujii, Shinya
    Hashimoto, Yuichi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2014, 62 (10) : 979 - 988
  • [35] Discovery and characterization of selective CDK9 small molecule inhibitors in preclinical tumor models
    Heuer, Timothy
    CANCER RESEARCH, 2009, 69
  • [36] Inhibition of the mitochondrial fission protein dynamin-related protein 1 (Drp1) impairs mitochondrial fission and mitotic catastrophe after x-irradiation
    Yamamori, Tohru
    Ike, Satoshi
    Bo, Tomoki
    Sasagawa, Tomoya
    Sakai, Yuri
    Suzuki, Motofumi
    Yamamoto, Kumiko
    Nagane, Masaki
    Yasui, Hironobu
    Inanami, Osamu
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26 (25) : 4607 - 4617
  • [37] Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy
    Bereketeab Haileselassie
    Amit U. Joshi
    Paras S. Minhas
    Riddhita Mukherjee
    Katrin I. Andreasson
    Daria Mochly-Rosen
    Journal of Neuroinflammation, 17
  • [38] Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy
    Haileselassie, Bereketeab
    Joshi, Amit U.
    Minhas, Paras S.
    Mukherjee, Riddhita
    Andreasson, Katrin I.
    Mochly-Rosen, Daria
    JOURNAL OF NEUROINFLAMMATION, 2020, 17 (01)
  • [39] Discovery of small molecule inhibitors of ADAR1
    Buker, Shane M.
    Blakemore, Stephen J.
    Boriack-Sjodin, P. Ann
    Collins, Cindy
    Copeland, Robert A.
    Duncan, Kenneth W.
    Ericsson, Anna
    Garadino, Alexandra
    Greene-Colozzi, April
    Leger, Nathalie
    Lockbaum, Gordon
    Raman, Anugraha
    Ribich, Scott
    Sickmier, Allen
    Sparling, Brian S.
    Wu, Jie
    Silver, Serena
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [40] Discovery of Potent Allosteric DRP1 Inhibitors by Disrupting Protein-Protein Interaction with MiD49
    Furuya, Takeru
    Lin, Jean
    Afanaseva, Arina
    Molz, Lisa
    Lagu, Bharat
    Ma, Bin
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (08): : 1095 - 1099